American International Group’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-349
Closed -$12K 3105
2022
Q1
$12K Buy
349
+23
+7% +$1.5K ﹤0.01% 3071
2021
Q4
$35K Sell
326
-10
-3% -$1.31K ﹤0.01% 3034
2021
Q3
$55K Sell
336
-8
-2% -$1.52K ﹤0.01% 2981
2021
Q2
$91 Buy
344
+255
+287% +$80.2K ﹤0.01% 2896
2021
Q1
$36 Buy
89
+2
+2% +$893 ﹤0.01% 3048
2020
Q4
$35 Buy
+87
New +$27.1K ﹤0.01% 3027

Other funds holding BDSX

American International Group's BDSX Position: Q2 2022 in Review

American International Group sold out of Biodesix (BDSX) in Q2 2022, closing a stake of 349 shares — an estimated $12K sold.

American International Group first reported a position in BDSX in Q4 2020 and held it in 6 quarters. The position peaked at $55K in Q3 2021. 36 funds tracked by Wall St. Rank hold BDSX as of Q2 2022.

  • American International Group reported no remaining Biodesix position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 349 Biodesix shares in Q2 2022, an estimated $12K.
  • American International Group first reported a position in Biodesix in Q4 2020 and held it in 6 quarters.
  • American International Group's Biodesix position peaked at $55K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held Biodesix as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.